Pharmafile Logo
Pharmafocus logo
Advanced Search

Autolus announces positive primary endpoint data in FELIX trial

December 13, 2022
Research and Development

Autolus Therapeutic, a clinical-stage biopharmaceutical company, has announced that the phase 2 FELIX clinical trial of obecabtagene autoleucel (obe-cel) in …

News

Seagen shares data for Adcetris combination for Hodgkin Lymphoma

December 13, 2022
Research and Development

Adcetris has long been one of Seagen’s top-selling and expanding products, and it has announced that the drug appeared successful …

News

RemeGen’s RC118 granted two orphan drug designations by FDA

December 13, 2022
Medical Communications

Chinese commercial-stage biotechnology company RemeGen has announced that RC118 for injection – its latest antibody-drug conjugate (ADC) – has been …

News

New blood cancer treatment appears successful for most trial patients

December 12, 2022
Research and Development

A new and experimental immunotherapy treatment has appeared successful in treating patients with multiple myeloma in an ongoing phase 1/2 …

News

Amgen expected to buy Horizon at valuation of $26bn

December 12, 2022
Sales and Marketing

Amgen Inc is expected to acquire biotech firm Horizon Therapeutics Plc at a valuation of $26bn. This would be Amgen’s …

News

UK Strep A death toll rises to 15

December 9, 2022
Medical Communications

Data from the UK Health Security Agency (UKHSA) show that 15 children under the age of 15 have now died …

News

FDA priority review given to Pfizer’s RSV vaccine for older adults

December 9, 2022
Medical Communications

Pfizer has announced that the FDA has accepted its application for a respiratory syncytial virus (RSV) vaccine for older adults, …

News

Biocorp receives FDA 510(k) approval for Mallya device

December 8, 2022
Medical Communications

French medical devices company, Biocorp, has received the FDA’s 510(k) approval for diabetes care device, Mallya. The device is a …

News

Novartis and MorphoSys sign $23m deal

December 8, 2022
Sales and Marketing

MorphoSys has announced that it will sell its worldwide licensing rights to its preclinical cancer programme to Novartis in exchange …

News

AbbVie to enter deal with HotSpot for up to $335m

December 7, 2022
Sales and Marketing

AbbVie and HotSpot Therapeutics have begun working on a licensing option deal for HotSpot’s preclinical small-molecule allosteric therapy, which will …

News

EMA accepts marketing authorisation application for ALS treatment, tofersen

December 7, 2022
Sales and Marketing

The European Medicines Agency (EMA) has accepted a marketing authorisation application (MAA) for tofersen. The drug would treat superoxide dismutase …

News

Positive results for BioVie’s Parkinson’s and Alzheimer’s phase 2 trials

December 6, 2022
Research and Development

BioVie has announced positive results from two phase 2 trials which have been assessing NE3107’s efficacy in treating Parkinson’s Disease …

News
national-cancer-institute-uurfmwa25f0-unsplash

Nkarta data supports natural killer cells in cancer treatment

December 6, 2022
Research and Development

San Francisco, US-based Nkarta have been assessing the power of natural killer (NK) cells in oncology treatments. The treatment is …

News

Aptamer Group sign deals to develop Optimer solutions

December 5, 2022
Business Services

Aptamer Group has announced a selection of contracts aimed at exploring Optimer technology, which will offer new strategies for therapeutics …

News

Innovent Biologics and UNION Therapeutics announce first dosing of Chinese subject in phase 1 study

December 5, 2022
Research and Development

Innovent Biologics, a biopharmaceutical company which develops, manufactures and commercialises medicines for the treatment of illnesses within the scope of …

News

Amgen’s obesity drug appears promising with few side effects

December 5, 2022
Research and Development

Amgen Inc’s new obesity drug has appeared promising in its small phase 1 trial, meaning they will be able to …

News

New insights into HIV vaccine revealed by researchers

December 5, 2022
Research and Development

Although researchers have previously always struggled to develop an efficient HIV vaccine, the results of a first-in-human clinical trial for …

News

Scottish Medicines Consortium approves Bayer’s Kerendia for NHS Scotland

December 2, 2022
Medical Communications

The Scottish Medicines Consortium (SMC) has given the green light to Bayer’s Kerendia (finerenone), a chronic kidney disease (CKD) drug …

News

GSK’s two new cancer drugs look promising

December 2, 2022
Research and Development

GlaxoSmithKline (GSK) appear to be making some positive progress in their oncology department, with drugs for both myelofibrosis and endometrial …

News

AstraZeneca and MSD launch prostate cancer awareness campaign

December 2, 2022
Medical Communications

AstraZeneca and MSD (known as Merck & Co. in the United States and Canada) have announced their collaborative global prostate …

News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025